PSA Prostate Cancer Screening Does More Harm Than Good, USPSTF Concludes
20:00 EDT 21 May 2012 | Elsevier Business Intelligence
Citing evidence that prostate-specific antigen (PSA) screening is associated with significant harms, the U.S. Preventive Services Task Force now recommends against the prostate cancer screening test for all men, regardless of age.
Original Article: PSA Prostate Cancer Screening Does More Harm Than Good, USPSTF Concludes
More From BioPortfolio on "PSA Prostate Cancer Screening Does More Harm Than Good, USPSTF Concludes"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
